From: MR diffusion versus MR perfusion in patients with ovarian tumors; how far could we get?
Demographic data | Number | Percent |
---|---|---|
Clinical presentations* | ||
Pelvic pain | 30/47 | 63.82% |
Pelvic and/or abdominal swelling | 6/47 | 12.76% |
Secondary infertility | 7/47 | 14.89% |
Postmenopausal bleeding | 4/47 | 8.51% |
Menstrual history | ||
Premenopausal | 30/47 | 63.82 % |
Postmenopausal | 17/47 | 36.17 % |